GSK 投资逾 8 亿美元扩建宾州生物制药中心 新增 300 多个岗位
宾夕法尼亚州州长 Josh Shapiro 与州社区与经济发展部部长 Rick Siger 10 月 9 日宣布，全球生物制药公司 GSK 将投资逾 8 亿美元，扩建位于 Montgomery County Upper Merion Township 的设施。项目预计未来五年新增 300 多个岗位，并保留全州约 4,500 个全职岗位。
扩建后的园区将把商业化生产、研发和先进数字能力整合为生物制药创新与制造中心，包括可支持临床与商业供应的生物药工厂、研发中试厂、质量控制实验室和制造科学与技术中心，计划 2027 年开工。这是 GSK 在 Shapiro 任内第二次在宾州大手笔扩建，两处投资合计近 17 亿美元。（资料来源：宾夕法尼亚州社区与经济发展部）
GSK to Invest More Than $800 Million in Pennsylvania Biopharma Hub, Creating Over 300 Jobs
Pennsylvania Governor Josh Shapiro and Department of Community and Economic Development Secretary Rick Siger announced on October 9 that GSK will invest more than $800 million to expand its Upper Merion Township site in Montgomery County. The project is expected to create more than 300 jobs over five years and retain about 4,500 full-time jobs across the Commonwealth.
Construction is planned to begin in 2027. The expanded campus will combine commercial-scale biologics manufacturing, a co-located R&D pilot plant, a centralized quality-control lab and a manufacturing science and technology hub, with advanced digital capabilities. It is GSK's second major Pennsylvania expansion under Shapiro, bringing the company's announced investment in the state to nearly $1.7 billion. (Source: Pennsylvania Department of Community and Economic Development)
图片来源：Wikimedia Commons · Petah tikva teva factory.jpg · CC BY-SA 4.0